Analystreport

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Hong Kong Pharma Digital Technology Holdings Limited - Ordinary shares  (HKPD)